BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30485686)

  • 1. Recombined humanized endostatin-induced suppression of HMGB1 expression inhibits proliferation of NSCLC cancer cells.
    Meng FJ; Wang S; Yan YJ; Wang CY; Guan ZY; Zhang J
    Thorac Cancer; 2019 Jan; 10(1):90-95. PubMed ID: 30485686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
    Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
    Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549.
    Li ZY; Zhu F; Hu JL; Peng G; Chen J; Zhang S; Chen X; Zhang RG; Chen LJ; Liu P; Luo M; Sun ZH; Ren JH; Huang LL; Wu G
    Tumour Biol; 2011 Aug; 32(4):677-87. PubMed ID: 21442281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endostatin exerts radiosensitizing effect in non-small cell lung cancer cells by inhibiting VEGFR2 expression.
    Liu L; Qiao Y; Hu C; Liu Y; Xia Y; Wang L; Liu B; Chen H; Jiang X
    Clin Transl Oncol; 2016 Jan; 18(1):18-26. PubMed ID: 26542176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
    Xiao P; Liu WL
    Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of recombinant human endostatin and docetaxel on human umbilical vein endothelial cells in different growth states.
    Xu WJ; Huang C; Wang J; Jiang RC; Wang LC; Lin L; Liu ZJ; Sun BC; Li K
    Chin Med J (Engl); 2011 Sep; 124(18):2883-9. PubMed ID: 22040497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethyl pyruvate suppresses the growth, invasion and migration and induces the apoptosis of non‑small cell lung cancer cells via the HMGB1/RAGE axis and the NF‑κB/STAT3 pathway.
    Liu Q; Huo Y; Zheng H; Zhao J; Jia L; Wang P
    Oncol Rep; 2019 Aug; 42(2):817-825. PubMed ID: 31173265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endostar, a modified endostatin inhibits non small cell lung cancer cell in vitro invasion through osteopontin-related mechanism.
    Ni Q; Ji H; Zhao Z; Fan X; Xu C
    Eur J Pharmacol; 2009 Jul; 614(1-3):1-6. PubMed ID: 19389394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells.
    Ma Y; Kang S; Wu X; Han B; Jin Z; Guo Z
    Tumori; 2018 Oct; 104(5):338-343. PubMed ID: 28885675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recombinant human endostatin induces apoptosis of human umbilical venous endothelial cells].
    Yang F; He YL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):978-80. PubMed ID: 16864091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of rh-endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh-endostatin plus pemetrexed maintenance in non-small cell lung cancer: A retrospective comparison with standard chemotherapy.
    Zhou S; Zuo L; He X; Pi J; Jin J; Shi Y
    Thorac Cancer; 2018 Nov; 9(11):1354-1360. PubMed ID: 30152052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
    Jiao P; Hou J; Yao M; Wu J; Ren G
    Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis.
    Yan H; Guo W; Li K; Tang M; Zhao X; Lei Y; Nie CL; Yuan Z
    Exp Cell Res; 2018 Oct; 371(1):50-62. PubMed ID: 30055135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling.
    Ren Y; Cao L; Wang L; Zheng S; Zhang Q; Guo X; Li X; Chen M; Wu X; Furlong F; Meng Z; Xu K
    Cell Death Dis; 2021 Sep; 12(10):858. PubMed ID: 34552063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world outcomes of various regimens of recombinant human endostatin combined with chemotherapy in non-driver gene mutation advanced non-small cell lung cancer.
    Wang Z; Zhang H; Zhou C; Long X; Guan R; Yang N; Zhang Y
    Cancer Med; 2019 Apr; 8(4):1434-1441. PubMed ID: 30762300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis.
    Qiu Z; Pan XX; You DY
    Neoplasma; 2020 Jul; 67(4):871-879. PubMed ID: 32386483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of recombinant human endostatin during peri-radiotherapy period in advanced non-small-cell lung cancer.
    Zhu J; Chen G; Niu K; Feng Y; Xie L; Qin S; Wang Z; Li J; Lang S; Zhuo W; Chen Z; Sun J
    Future Oncol; 2022 Mar; 18(9):1077-1087. PubMed ID: 34986655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effects of recombinant human endostatin on the metastatic potential and invasiveness of hepatocellular carcinoma HCCLM6 cells in vitro].
    Zhang PH; Qin J; Li AM; Ding XM; Yang-feng D; Rong-cheng L
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):658-61. PubMed ID: 18495614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IOX-101 Reverses Drug Resistance Through Suppression of Akt/mTOR/NF-κB Signaling in Cancer Stem Cell-Like, Sphere-Forming NSCLC Cell.
    Fayi MA; Alamri A; Rajagopalan P
    Oncol Res; 2020 Mar; 28(2):177-189. PubMed ID: 31771696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.